Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection
about
Dengue virus targets the adaptor protein MITA to subvert host innate immunityLipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and VirulenceInflammasome/IL-1β Responses to Streptococcal PathogensRNA mediated Toll-like receptor stimulation in health and diseaseNLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STINGSalmonella Suppresses the TRIF-Dependent Type I Interferon Response in Macrophages.The innate immune response elicited by Group A Streptococcus is highly variable among clinical isolates and correlates with the emm type.Type I Interferon Induction by Neisseria gonorrhoeae: Dual Requirement of Cyclic GMP-AMP Synthase and Toll-like Receptor 4.Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokinesResponses of innate immune cells to group A Streptococcus.DNase Sda1 allows invasive M1T1 Group A Streptococcus to prevent TLR9-dependent recognitionProtein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells.Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2.Host responses to group a streptococcus: cell death and inflammationSpontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses.D-Alanylation of Teichoic Acids and Loss of Poly-N-Acetyl Glucosamine in Staphylococcus aureus during Exponential Growth Phase Enhance IL-12 Production in Murine Dendritic Cells.The Influence of Programmed Cell Death in Myeloid Cells on Host Resilience to Infection with Legionella pneumophila or Streptococcus pyogenes.A MyD88-JAK1-STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus.Failure to induce IFN-β production during Staphylococcus aureus infection contributes to pathogenicity.Type I interferons: diversity of sources, production pathways and effects on immune responses.STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection.Confounding roles for type I interferons during bacterial and viral pathogenesis.Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.TLR7 and TLR3 Sense Brucella abortus RNA to Induce Proinflammatory Cytokine Production but They Are Dispensable for Host Control of Infection.Differential Ability of Bovine Antimicrobial Cathelicidins to Mediate Nucleic Acid Sensing by Epithelial Cells.The Emerging Roles of STING in Bacterial Infections.Type I interferon response to extracellular bacteria in the airway epithelium.Molecular basis of DNA recognition in the immune system.The Roles of Type I Interferon in Bacterial Infection.Type I Interferons in Bacterial Infections: A Balancing Act.Bacterial RNA mediates activation of caspase-1 and IL-1β release independently of TLRs 3, 7, 9 and TRIF but is dependent on UNC93BRegulating STING in health and diseaseToll-Like Receptor 3/TRIF-Dependent IL-12p70 Secretion Mediated by Streptococcus pneumoniae RNA and Its Priming by Influenza A Virus Coinfection in Human Dendritic Cells.Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for Staphylococcus aureus cutaneous host defense.The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection.cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice.Group B Streptococcus Degrades Cyclic-di-AMP to Modulate STING-Dependent Type I Interferon Production.Interferon α-Enhanced Clearance of Group A Streptococcus Despite Neutropenia.Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis.Invasive group A Streptococcus disease in French-Canadian children is not associated with a defect in MyD88/IRAK4-pathway
P2860
Q21558785-CC63052E-70DF-47CB-87E8-1A5EC79144DAQ26741954-EFCB7016-BEC7-446D-86F0-794687F78343Q26779173-6D834428-064E-4C36-89DC-94021CE96170Q26999252-7EB336EA-DD60-444F-B125-E90008AF7F69Q28975619-5CA97D79-1527-4843-B9F0-EFB6EF82CDDAQ30277329-43EAF49C-8437-44E3-9449-2A6BAC49B31EQ31171824-D098FAEE-1D10-4D1D-B835-BECC1DF623B3Q33592743-3B853329-56C3-4E42-9A25-55119C4518E1Q33603081-AD37FD1C-CEAC-4533-BE83-6629438365EAQ34279891-0EC66149-8134-43A7-84BB-3C586EEEFF07Q34311559-4F4988D9-55B2-4AB9-A293-69DFD33E9A5DQ34708883-2039E461-40F7-482E-AE1E-42180642FDF6Q35164770-80DD88C2-4BC5-4F7B-9C84-885901707F3AQ35233558-065DABA2-A168-4FA1-8B0B-DAFB9C173EFEQ35889350-30913F98-2264-40BC-9903-733628E55908Q35922364-2FC27992-2E92-41D7-A52D-EC8E9EBD9EDEQ36223568-AD3DA826-D5FC-4E2F-8AC1-E0E8F0C6FEEBQ36302666-1834B555-F70C-45FD-9A01-49BE4BF45DE0Q36339179-1531B1DD-5115-46DC-8FA2-7133E298DC81Q36611339-6FA22D7E-D803-43A3-9729-5A1DC2309C98Q36872696-1CCE782E-C17C-4F08-8EFD-B4AC06E8B85CQ37339050-5061B756-1A64-449D-8FE6-A39992779646Q37559660-6602B3E1-FC38-4CA5-ABB3-55BE270FE227Q37598367-FF4D5F8F-B749-4696-AA8D-B9D643418AE9Q37617469-44DF81FF-468A-44D5-9879-48EEFDC9324EQ37833954-AA4994C2-1507-4581-ABAB-259C867845B0Q37945396-BFF57DF9-1DE5-4110-82AD-98C056198C3AQ38082423-6E4E6C3F-3ABE-49F3-B419-A229F6B51E73Q38860235-91759FA4-8BE9-4776-8D9A-93FA7F65B9CBQ39084591-896D5988-22F2-417F-98E4-00021CB894EDQ39341490-46E2140A-834E-4A5A-9822-B6C4F3FD9486Q39360861-141C7B09-461B-4A77-9E9A-E438E136CEF4Q39597122-9B480103-498E-413E-AA9B-5B132DB7114AQ40136060-5E5C0B61-853E-44B7-8D2F-BBFFB03FAE7BQ40212847-DC545889-C669-4D1D-A48D-9EE3B952C9CEQ40245668-29510CCA-5D1A-4E15-9710-3FC0443DC9BBQ40613531-FFA80816-A874-437D-B684-AE7B04E1839BQ40638602-A481E192-355A-4A34-AFEC-DD710F9D4237Q41116868-1CE1318C-97BE-4C4D-990F-C0DEE50BF8FCQ41961476-2E864682-E23D-4134-AEC9-C44A85005F87
P2860
Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Type I interferon production i ...... s required for host protection
@ast
Type I interferon production i ...... s required for host protection
@en
type
label
Type I interferon production i ...... s required for host protection
@ast
Type I interferon production i ...... s required for host protection
@en
prefLabel
Type I interferon production i ...... s required for host protection
@ast
Type I interferon production i ...... s required for host protection
@en
P2093
P2860
P1433
P1476
Type I interferon production i ...... s required for host protection
@en
P2093
Barbara Drobits
Franz Kratochvill
Harald Hartweger
Marton Janos
Nina Gratz
Pavel Kovarik
Stefanie Sigel
Sylvia Knapp
Ulrich Matt
Xiao-Dong Li
P2860
P304
P356
10.1371/JOURNAL.PPAT.1001345
P577
2011-05-19T00:00:00Z